ALDEA Pharmaceuticals, Inc. — Form D
ALDEA Pharmaceuticals, Inc. of REDWOOD CITY, CA, a company, filed a Form D exempt-offering notice with the SEC on 2014-08-25. The offering totals $24.1M, of which $9.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2014-08-25
- Form: D
- Accession: 0001531984-14-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $24.1M
- Amount sold: $9.3M
- Remaining: $14.8M
- Investors: 5
- Date of first sale: 2014-08-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-223549
Issuer
- Name: ALDEA Pharmaceuticals, Inc.
- CIK: 0001531984
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: 3696 HAVEN AVE., SUITE C, REDWOOD CITY, CA, 94063
- Phone: 650 241-1600
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Wende Hutton | Director | Menlo Park, CA |
| Howard Rosen | Director | Woburn, MA |
| Timothy Shannon | Director | Stamford, CT |
| John Walker | Director | Birmingham, AL |
| William Yelle | Director | MORRISVILLE, NC |
| EVGENY ZAYTSEV | Director | SAN FRANCISCO, CA |
| Vernon Jiang, Ph.D. | Executive Officer | Redwood City, CA |
| Richard Shames, M.D. | Executive Officer | Redwood City, CA |
| Wenjin Yang | Executive Officer | Redwood City, CA |
| William Yelle | Executive Officer | MORRISVILLE, NC |
| Timothy Shannon | Executive Officer | Stamford, CT |
| Daria Mochly-Rosen | Director | Palo Alto, CA |
Other filings by this issuer (4)
More